244 related articles for article (PubMed ID: 28430389)
61. Dual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3.
Chen L; Mooso BA; Jathal MK; Madhav A; Johnson SD; van Spyk E; Mikhailova M; Zierenberg-Ripoll A; Xue L; Vinall RL; deVere White RW; Ghosh PM
Clin Cancer Res; 2011 Oct; 17(19):6218-28. PubMed ID: 21844010
[TBL] [Abstract][Full Text] [Related]
62. Selective growth regulatory and pro-apoptotic effects of DIM is mediated by AKT and NF-kappaB pathways in prostate cancer cells.
Li Y; Chinni SR; Sarkar FH
Front Biosci; 2005 Jan; 10():236-43. PubMed ID: 15574364
[TBL] [Abstract][Full Text] [Related]
63. Curcumin-Gene Expression Response in Hormone Dependent and Independent Metastatic Prostate Cancer Cells.
Katta S; Srivastava A; Thangapazham RL; Rosner IL; Cullen J; Li H; Sharad S
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31581661
[TBL] [Abstract][Full Text] [Related]
64. Psoralidin, an herbal molecule, inhibits phosphatidylinositol 3-kinase-mediated Akt signaling in androgen-independent prostate cancer cells.
Kumar R; Srinivasan S; Koduru S; Pahari P; Rohr J; Kyprianou N; Damodaran C
Cancer Prev Res (Phila); 2009 Mar; 2(3):234-43. PubMed ID: 19223576
[TBL] [Abstract][Full Text] [Related]
65. Veratramine Inhibits the Cell Cycle Progression, Migration, and Invasion via ATM/ATR Pathway in Androgen-Independent Prostate Cancer.
Kim HY; Lee SW; Choi SK; Ashim J; Kim W; Beak SM; Park JK; Han JE; Cho GJ; Ryoo ZY; Jeong J; Lee YH; Jeong H; Yu W; Park S
Am J Chin Med; 2023; 51(5):1309-1333. PubMed ID: 37385965
[TBL] [Abstract][Full Text] [Related]
66. Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases.
Rick FG; Schally AV; Szalontay L; Block NL; Szepeshazi K; Nadji M; Zarandi M; Hohla F; Buchholz S; Seitz S
Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1655-60. PubMed ID: 22307626
[TBL] [Abstract][Full Text] [Related]
67. Study on the influence of metformin on castration-resistant prostate cancer PC-3 cell line biological behavior by its inhibition on PLCε gene-mediated Notch1/Hes and androgen receptor signaling pathway.
Yang Y; Wu XH
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1918-1923. PubMed ID: 28485785
[TBL] [Abstract][Full Text] [Related]
68. Hexane Insoluble Fraction from Purple Rice Extract Retards Carcinogenesis and Castration-Resistant Cancer Growth of Prostate Through Suppression of Androgen Receptor Mediated Cell Proliferation and Metabolism.
Yeewa R; Naiki-Ito A; Naiki T; Kato H; Suzuki S; Chewonarin T; Takahashi S
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32093357
[TBL] [Abstract][Full Text] [Related]
69. Inorganic Selenium Induces Nonapoptotic Programmed Cell Death in PC-3 Prostate Cancer Cells Associated with Inhibition of Glycolysis.
Cui J; Yan M; Liu X; Yin S; Lu S; Fan L; Hu H
J Agric Food Chem; 2019 Sep; 67(38):10637-10645. PubMed ID: 31513389
[TBL] [Abstract][Full Text] [Related]
70. Epidermal growth factor receptor-related peptide inhibits growth of PC-3 prostate cancer cells.
Marciniak DJ; Rishi AK; Sarkar FH; Majumdar AP
Mol Cancer Ther; 2004 Dec; 3(12):1615-21. PubMed ID: 15634655
[TBL] [Abstract][Full Text] [Related]
71. Decursin inhibits EGFR-ERK1/2 signaling axis in advanced human prostate carcinoma cells.
Bhat TA; Dheeraj A; Nambiar DK; Singh SP; Yim DS; Singh RP
Prostate; 2023 May; 83(6):534-546. PubMed ID: 36597263
[TBL] [Abstract][Full Text] [Related]
72. Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment.
Makino T; Izumi K; Mizokami A
Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33921329
[TBL] [Abstract][Full Text] [Related]
73. Synergistic effect of ethaselen and selenite treatment against A549 human non-small cell lung cancer cells.
Xu W; Ma WW; Zeng HH
Asian Pac J Cancer Prev; 2014; 15(17):7129-35. PubMed ID: 25227802
[TBL] [Abstract][Full Text] [Related]
74. Androgen receptor activation reduces the endothelial cell proliferation through activating the cSrc/AKT/p38/ERK/NFκB-mediated pathway.
Huo YN; Yeh SD; Lee WS
J Steroid Biochem Mol Biol; 2019 Nov; 194():105459. PubMed ID: 31470108
[TBL] [Abstract][Full Text] [Related]
75. Inhibiting TNF-mediated signaling: a novel therapeutic paradigm for androgen independent prostate cancer.
Srinivasan S; Kumar R; Koduru S; Chandramouli A; Damodaran C
Apoptosis; 2010 Feb; 15(2):153-61. PubMed ID: 19851870
[TBL] [Abstract][Full Text] [Related]
76. Andrographolide targets androgen receptor pathway in castration-resistant prostate cancer.
Liu C; Nadiminty N; Tummala R; Chun JY; Lou W; Zhu Y; Sun M; Evans CP; Zhou Q; Gao AC
Genes Cancer; 2011 Feb; 2(2):151-9. PubMed ID: 21779488
[TBL] [Abstract][Full Text] [Related]
77. Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers.
Zhang A; Lau NA; Wong A; Brown LG; Coleman IM; De Sarkar N; Li D; DeLucia DC; Labrecque MP; Nguyen HM; Conner JL; Dumpit RF; True LD; Lin DW; Corey E; Alumkal JJ; Nelson PS; Morrissey C; Lee JK
Cancer Res Commun; 2023 Nov; 3(11):2358-2374. PubMed ID: 37823778
[TBL] [Abstract][Full Text] [Related]
78. Dual blockade of PKA and NF-κB inhibits H2 relaxin-mediated castrate-resistant growth of prostate cancer sublines and induces apoptosis.
Vinall RL; Mahaffey CM; Davis RR; Luo Z; Gandour-Edwards R; Ghosh PM; Tepper CG; de Vere White RW
Horm Cancer; 2011 Aug; 2(4):224-38. PubMed ID: 21789713
[TBL] [Abstract][Full Text] [Related]
79. Small molecule DTDQ exerts anti-metastatic effects in DU145 human castration-resistant prostate cancer cells via modulations of ERK, JNK, p38 and c-Myc signaling pathways.
Son J; Lee SY
Bioorg Med Chem Lett; 2020 Jul; 30(13):127223. PubMed ID: 32371099
[TBL] [Abstract][Full Text] [Related]
80. Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer.
Abd Wahab NA; Lajis NH; Abas F; Othman I; Naidu R
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32131560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
